Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Avalo Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AVTX
Nasdaq
8731
https://www.avalotx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Avalo Therapeutics Inc
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
- Apr 2nd, 2024 11:00 am
Avalo Reports 2023 Financial Results and Provides Business Updates
- Mar 29th, 2024 8:01 pm
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
- Mar 27th, 2024 8:01 pm
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
- Dec 27th, 2023 12:00 pm
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
- Dec 7th, 2023 12:00 pm
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
- Nov 9th, 2023 12:00 pm
Avalo Completes Divestiture of AVTX-800 Series
- Oct 31st, 2023 11:00 am
BestGrowthStocks.com Issues a Comprehensive Analysis of Avalo Therapeutics
- Sep 27th, 2023 12:00 pm
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
- Sep 26th, 2023 11:00 am
Avalo Enters into Agreement to Divest AVTX-800 Series
- Sep 12th, 2023 11:00 am
Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 6th, 2023 11:00 am
Avalo Reports Second Quarter 2023 Financial Results and Provides Business Updates
- Aug 3rd, 2023 11:00 am
Avalo to Participate in SVB Securities Therapeutics Forum
- Jul 6th, 2023 8:01 pm
Avalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthma
- Jun 26th, 2023 11:00 am
Avalo to Present at the Jefferies Healthcare Conference
- Jun 1st, 2023 11:00 am
Avalo Announces Appointment of Michael Croft, Ph.D. and Jeff Edelson, M.D. to its Scientific Advisory Board
- May 22nd, 2023 11:00 am
Avalo to Present at ATS 2023 Respiratory Innovation Summit
- May 15th, 2023 11:00 am
Avalo to Present at the 2023 RBC Capital Markets Global Healthcare Conference
- May 10th, 2023 11:00 am
Avalo Reports First Quarter 2023 Financial Results and Provides Business Updates
- May 4th, 2023 8:01 pm
Scroll